Elsevier

Joint Bone Spine

Volume 86, Issue 4, July 2019, Pages 445-449
Joint Bone Spine

Review
The negative Hawthorne effect: Explaining pain overexpression

https://doi.org/10.1016/j.jbspin.2018.10.003Get rights and content

Highlights

  • Symptom overexpression defines the negative Hawthorne effect and should be differentiated from the nocebo effect, characterized by increased symptom experience.

  • An example of the negative Hawthorne effect can be found in patients who are fully relaxed yet give a pain intensity score of 11 on a 10-point Scale.

  • Excessively frequent pain intensity evaluations performed using methods that involve negative suggestions, such as having to consider the “worst pain imaginable”, may induce negative Hawthorne effects.

  • Many other factors can induce negative Hawthorne effects.

  • A sequence of strong negative Hawthorne effects before treatment initiation followed by strong positive Hawthorne effects once the treatment is started may explain a large part of observed improvements.

Abstract

In medicine, the positive Hawthorne effect is defined as decreased symptom expression due to being observed. This effect occurs in addition to the decrease in symptom experience due to the placebo effect. Symptom overexpression, in contrast, whether related to conscious or to unconscious factors, defines the negative Hawthorne effect, which should be distinguished from the nocebo effect, defined as an increase in symptom experience. For instance, the negative Hawthorne effect can result in patients who seem fully relaxed evaluating their pain intensity at 11 on a 10-point Scale. The negative Hawthorne effect stems from multiple factors including a wish to receive greater consideration or priority management status; concern about failing to meet criteria for receiving a new treatment or being included in a therapeutic trial; conformism related to cultural factors or to circumstance (e.g., avoiding the canceling of a surgical procedure in the event of a last-minute improvement); disease mongering; a desire to be taken seriously by family and friends; a quest for secondary benefits; use of the evaluation to express frustration about being ill or bitterness at receiving a lower level of support; a gap between the expectation of complete relief and the true effectiveness of treatments; and pain exacerbation, with loss of reliability of pain intensity measurements, due to anxiety, guilt, depression, nervosity, catastrophizing, kinesiophobia, or repeated evaluations using methods that involve negative suggestions such as considering the worst pain imaginable. A sequence of a strong negative Hawthorne effect before treatment prescription followed by a strong positive Hawthorne effect after treatment initiation may make a greater contribution than the placebo effect to the improvements produced by treatments for pain.

Section snippets

Conformism as a source of negative Hawthorne effects

The positive Hawthorne effect results in the subject trying to satisfy the observer's expectation of a good outcome. In the seminal experiment [1], manufacturing employees at Hawthorne Works demonstrated increased productivity during an inspection intended to determine whether improved lighting would benefit productivity. The observers noticed that the increase in productivity persisted after the end of the observation period, when the lighting was brought down to its previous level unbeknownst

Pushing for faster management as a reason for negative Hawthorne effects

Pain overexpression due to more or less conscious mechanisms may occur when competition for access to care leads patients to fear they will not be considered as priorities. For instance, understaffing in emergency departments or extended-stay facilities prompt patient to exaggerate the expression of their pain. This mechanism may operate also in pain control centers, which often have long waiting times.

A desire to meet activity criteria as a source for negative Hawthorne effects

In everyday practice, gaining access to certain new medications is theoretically dependent on meeting criteria for a minimum level of disease activity. For instance, TNFα antagonist therapy for spondyloarthritis is indicated only if the BASDAI is above 4/10 [19]. Patients who are aware of these activity criteria may exaggerate their reports of pain to gain access to the drug.

Publicity for a new therapeutic method may lead patients to believe that switching from their current treatment to the

Concern about not being taken seriously as a source of negative Hawthorne effects

Patients may exaggerate the expression of their pain if they fear that their healthcare providers, co-workers, and/or family may underestimate their suffering. A trivial example is the dramatic behavior of soccer players injured on the field, which is designed to increase the referee's evaluation of the severity of the foul. Such behavior is not seen in rugby matches, during which the often-rougher physical contact is not punished in the same way.

A quest for secondary benefits as a source of negative Hawthorne effects

Patients may exaggerate their complaints to obtain compensation for a work-related injury or to perpetuate a situation they feel is advantageous to them, for instance if they are seeking financial reparation or disability status, a sick leave extension, or the granting of social benefits that depend on being scored above a severity cutoff. This type of negative Hawthorne effect is known as malingering, which is intermediate between simulation and accident neurosis [22].

Frustration with the evaluator as a source of negative Hawthorne effects

Patients who are frustrated about not achieving the expected level of relief may exaggerate their complaints to emphasize the inadequacy of their management, even when they have received the best care possible. This behavior may be encouraged by the satisfaction questionnaires handed to patients at discharge, which may lead patients to behave as litigious consumers or to adopt a passive-aggressive behavior. Similar effects may be produced by polemical statements likening healthcare

Interference between the evaluation and various emotions as a source of negative Hawthorne effects

Various emotions may increase the level of pain expression. Anxiety is among them. Patients may fear an increase in pain intensity and a worsening of pain-related limitations that would make them unable to carry out their everyday activities. In this situation, adding an anxiolytic agent may be at least as effective as an analgesic and may also prevent analgesic misuse [24]. Reassurance by the healthcare providers should remain the best means of avoiding anxiety-induced exacerbations in pain

Repeated evaluations as a source of negative Hawthorne effects

Despite the use and misuse of analgesics induced by campaigns to promote pain control, first in the US then elsewhere, the mean pain intensity in the treated population does not seem diminished. Thus, three-quarters of patients using opioids reported persistent severe pain [31]. This finding is further confirmation that analgesics are less effective than believed by the general public and a substantial proportion of healthcare professionals. This misguided optimism can be ascribed in part to

Conclusion

The possibility that negative Hawthorne effects can be induced indicates that:

  • patient evaluation is not a neutral act, as repeated evaluations may alter the results;

  • suggestion can affect not only the experience of symptoms (placebo effect), but also their expression (positive Hawthorne effect, which should be called into play [39], and negative Hawthorne effects, which should be countered); and;

  • negative Hawthorne effects may impair coping [33].

Some of the improvements documented during clinical

Disclosure of interest

The authors declare that they have no competing interest.

References (46)

  • L Koban et al.

    What's in a word? How instructions, suggestions, and social information change pain and emotion

    Neurosci Biobehav Rev

    (2017)
  • E -Bucourt et al.

    Comparison of the Big Five personality traits in fibromyalgia and other rheumatic diseases

    Joint Bone Spine

    (2017)
  • M Penhoat et al.

    High pain catastrophizing scores in one-fourth of patients on biotherapy for spondylarthritis or rheumatoid arthritis

    Joint Bone Spine

    (2014)
  • S Perrot et al.

    Kinesiophobia and physical therapy-related pain in musculoskeletal pain: A national multicenter cohort study on patients and their general physicians

    Joint Bone Spine

    (2018)
  • OM Fredheim et al.

    Chronic pain and use of opioids: a population-based pharmacoepidemiological study from the Norwegian prescription database and the Nord-Trøndelag health study

    Pain

    (2014)
  • F Bailly et al.

    Development and validation of a questionnaire categorizing behavioral strategies in patients with chronic low back pain

    Joint Bone Spine

    (2017)
  • F Bailly et al.

    Pain assessment in rheumatology-how can we do better? A literature review

    Joint Bone Spine

    (2016)
  • TI Usichenko et al.

    ‘Yes, we can’ utilize the Hawthorne effect to improve postoperative analgesia

    Br J Anaesth

    (2013)
  • L Vase et al.

    Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007

    Pain

    (2009)
  • JM Berthelot et al.

    Strong opioids for noncancer pain due to musculoskeletal diseases: Not more effective than acetaminophen or NSAIDs

    Joint Bone Spine

    (2015)
  • P Sedgwick et al.

    Understanding the Hawthorne effect

    BMJ

    (2015)
  • DF Kallmes et al.

    A randomized trial of vertebroplasty for osteoporotic spinal fractures

    N Engl J Med.

    (2009)
  • G Rossettini et al.

    Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain

    BMC Musculoskelet Disord

    (2018)
  • Cited by (0)

    View full text